We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The cancer tissue page shows antibody staining in 20 different cancers. The assay and annotation is described here.
This page starts with information about the protein evidence and, when applicable, also protein class. Below the summary, a selection of four standard cancer tissue samples is displayed as representative of the overall staining pattern. From left: colorectal cancer, breast cancer, prostate cancer and lung cancer. An additional 5th image can be added as a complement.
Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors
Protein evidence
Evidence at protein level
Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer
STAINING SUMMARYi
The cancer tissue summary page shows antibody staining in 20 different cancers. The assay and annotation is described here.
For each cancer, the fraction of samples with antibody staining/protein expression level high, medium, low, or not detected are provided by the blue-scale color-coding (as described by the color-coding scale in the box to the right). The length of the bar represents the number of patient samples analyzed (max=12 patients). The images and annotations can be accessed by clicking on the cancer name or protein expression bar. If more than one antibody is analyzed, the tabs at the top of the staining summary section can be used to toggle between the different antibodies. The tooltip function displays additional data for the features in the staining summary view.
Next to the cancer staining data, the protein expression data of normal tissues or specific cell types corresponding to each cancer are shown and protein expression levels are indicated by the blue-scale color coding.
At the bottom of the page, a summary of the overall protein expression pattern across the analyzed cancer tissues as well as information about literature conformity are presented.
Selected cases of colorectal, breast, ovarian, cervical, thyroid, skin, urothelial, head and neck cancers, gliomas and lymphomas showed moderate to strong nuclear positivity. Remaining cancers were weakly stained or negative.
GENE INFORMATIONi
Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.
This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.
At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.
Under the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50) (read more).
If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.
Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
PPARG-001
PPARG-002
PPARG-003
PPARG-004
PPARG-005
PPARG-007
PPARG-009
PPARG-013
PPARG-015
PPARG-017
PROTEIN INFORMATIONi
The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.
The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.
The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.
The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001012 [RNA polymerase II regulatory region DNA binding] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001228 [transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding] GO:0001890 [placenta development] GO:0002021 [response to dietary excess] GO:0002024 [diet induced thermogenesis] GO:0002674 [negative regulation of acute inflammatory response] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007507 [heart development] GO:0007584 [response to nutrient] GO:0008134 [transcription factor binding] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0008285 [negative regulation of cell proliferation] GO:0009409 [response to cold] GO:0009612 [response to mechanical stimulus] GO:0010033 [response to organic substance] GO:0010467 [gene expression] GO:0010468 [regulation of gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0014070 [response to organic cyclic compound] GO:0015909 [long-chain fatty acid transport] GO:0019216 [regulation of lipid metabolic process] GO:0019395 [fatty acid oxidation] GO:0019899 [enzyme binding] GO:0019903 [protein phosphatase binding] GO:0030224 [monocyte differentiation] GO:0030308 [negative regulation of cell growth] GO:0030331 [estrogen receptor binding] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0031000 [response to caffeine] GO:0031100 [organ regeneration] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0032966 [negative regulation of collagen biosynthetic process] GO:0033189 [response to vitamin A] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0035902 [response to immobilization stress] GO:0036270 [response to diuretic] GO:0042493 [response to drug] GO:0042593 [glucose homeostasis] GO:0042594 [response to starvation] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043065 [positive regulation of apoptotic process] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0043627 [response to estrogen] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045444 [fat cell differentiation] GO:0045598 [regulation of fat cell differentiation] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046321 [positive regulation of fatty acid oxidation] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048471 [perinuclear region of cytoplasm] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0048714 [positive regulation of oligodendrocyte differentiation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0050873 [brown fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0051974 [negative regulation of telomerase activity] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060100 [positive regulation of phagocytosis, engulfment] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0071285 [cellular response to lithium ion] GO:0071300 [cellular response to retinoic acid] GO:0071306 [cellular response to vitamin E] GO:0071379 [cellular response to prostaglandin stimulus] GO:0071380 [cellular response to prostaglandin E stimulus] GO:0071407 [cellular response to organic cyclic compound] GO:0071455 [cellular response to hyperoxia] GO:0090575 [RNA polymerase II transcription factor complex] GO:1901558 [response to metformin] GO:2000230 [negative regulation of pancreatic stellate cell proliferation]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0030522 [intracellular receptor signaling pathway]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006351 [transcription, DNA-templated] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006351 [transcription, DNA-templated] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding]
Nuclear receptors Predicted intracellular proteins Plasma proteins Transcription factors Zinc-coordinating DNA-binding domains Cancer-related genes Candidate cancer biomarkers COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes FDA approved drug targets Small molecule drugs Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001890 [placenta development] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0003707 [steroid hormone receptor activity] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0004955 [prostaglandin receptor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006355 [regulation of transcription, DNA-templated] GO:0006367 [transcription initiation from RNA polymerase II promoter] GO:0006629 [lipid metabolic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007165 [signal transduction] GO:0007186 [G-protein coupled receptor signaling pathway] GO:0007584 [response to nutrient] GO:0008144 [drug binding] GO:0008217 [regulation of blood pressure] GO:0008270 [zinc ion binding] GO:0010467 [gene expression] GO:0010745 [negative regulation of macrophage derived foam cell differentiation] GO:0010871 [negative regulation of receptor biosynthetic process] GO:0010887 [negative regulation of cholesterol storage] GO:0010891 [negative regulation of sequestering of triglyceride] GO:0015909 [long-chain fatty acid transport] GO:0019899 [enzyme binding] GO:0030224 [monocyte differentiation] GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] GO:0030855 [epithelial cell differentiation] GO:0032526 [response to retinoic acid] GO:0032869 [cellular response to insulin stimulus] GO:0033613 [activating transcription factor binding] GO:0033993 [response to lipid] GO:0035357 [peroxisome proliferator activated receptor signaling pathway] GO:0042593 [glucose homeostasis] GO:0042752 [regulation of circadian rhythm] GO:0042953 [lipoprotein transport] GO:0043401 [steroid hormone mediated signaling pathway] GO:0043565 [sequence-specific DNA binding] GO:0044212 [transcription regulatory region DNA binding] GO:0045087 [innate immune response] GO:0045165 [cell fate commitment] GO:0045600 [positive regulation of fat cell differentiation] GO:0045713 [low-density lipoprotein particle receptor biosynthetic process] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046965 [retinoid X receptor binding] GO:0048469 [cell maturation] GO:0048511 [rhythmic process] GO:0048662 [negative regulation of smooth muscle cell proliferation] GO:0050544 [arachidonic acid binding] GO:0050872 [white fat cell differentiation] GO:0051091 [positive regulation of sequence-specific DNA binding transcription factor activity] GO:0051393 [alpha-actinin binding] GO:0055088 [lipid homeostasis] GO:0055098 [response to low-density lipoprotein particle] GO:0060336 [negative regulation of interferon-gamma-mediated signaling pathway] GO:0060694 [regulation of cholesterol transporter activity] GO:0060850 [regulation of transcription involved in cell fate commitment] GO:0090575 [RNA polymerase II transcription factor complex]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003700 [transcription factor activity, sequence-specific DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0008270 [zinc ion binding] GO:0030522 [intracellular receptor signaling pathway] GO:0043565 [sequence-specific DNA binding]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding] GO:0004879 [RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding] GO:0005634 [nucleus] GO:0006355 [regulation of transcription, DNA-templated] GO:0030522 [intracellular receptor signaling pathway]
